Thank you for the question.
If I had another hour, I could probably adequately address it. In the short term, we need to develop a strategy.
The strategy should be based on the aging brain, not based on specific diseases. One of the failures of neuroscience research is that it's all based on Alzheimer's versus Parkinson's versus ALS—